Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. - Wikidata - awgldk - TriplyDB

Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.

Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.

http://www.wikidata.org/entity/Q34101137

about

Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study Proteomic analysis of cattle tick Rhipicephalus (Boophilus) microplus saliva: a comparison between partially and fully engorged females.Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.The oxidative stress product carboxyethylpyrrole potentiates TLR2/TLR1 inflammatory signaling in macrophages Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin.Hemopexin in severe inflammation and infection: mouse models and human diseases Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation Inflammatory targets of therapy in sickle cell disease.Dysregulation of the haem-haemopexin axis is associated with severe malaria in a case-control study of Ugandan children.A perspective on the role of extracellular hemoglobin on the innate immune system Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome.Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies Purified and recombinant hemopexin: protease activity and effect on neutrophil chemotaxis Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.Transfusion-Related Acute Lung Injury: The Work of DAMPs.Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.With blood in the joint - what happens next? Could activation of a pro-inflammatory signalling axis leading to iRhom2/TNFα-convertase-dependent release of TNFα contribute to haemophilic arthropathy?Heme on innate immunity and inflammation.Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.Heme as a Target for Therapeutic Interventions.MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients.Oxidized Hemoglobin Is Antigenic and Immunogenic in Lupus.Fanning the Fire: Can Methemoglobin Enhance Neutrophil Activation?Insulin attenuates TNFα-induced hemopexin mRNA: An anti-inflammatory action of insulin in rat H4IIE hepatoma cells.Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.Identification of oxidative modifications of hemopexin and their predicted physiological relevance.A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects.Revisiting the putative role of heme as a trigger of inflammation.Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage.

P2860

Q28266961-A1487A10-5F3F-4D66-941E-3795809ADE8F Q28540157-14BAC009-805F-4FE7-90D4-A35D24DC56BA Q30413641-F4780901-6F21-4F47-897A-1DA57C4AE3A3 Q33864443-60190344-4773-4A0C-A2B3-E3D97C93CBC3 Q34128646-1428C2AA-4B45-4D25-B637-670A545A00B9 Q34266987-247A4F37-F59E-45D0-8FDA-E82D696529E5 Q34448199-E31ED7F7-BEEC-44DB-A3A3-422EAFF831B5 Q35584877-67968515-23F2-4BDA-9B1A-6D016B9E5AF0 Q36186825-F23D7DB9-B4E4-4A97-9CA6-2951843FF9D1 Q36385224-7AD88D3A-CDFF-416C-8BFE-50B104E52EB6 Q36393876-7DA2CAA5-F002-4170-B3D9-46FFACCD4F69 Q36568887-7E359327-2A6B-44B8-B19E-1D5C6B6DC27B Q36628281-BC23099A-96DD-4068-B549-25815C19E6E1 Q36633879-AA5C9189-E4EE-4875-A3B0-33CF2AD9CA0B Q36870257-3942586E-3B2D-4C12-8B9B-76296255A26F Q37217041-6B7842E7-237F-4ACE-A970-396CB1739D09 Q37279771-2CE44DD9-A588-4CD9-A824-A912CF842650 Q37713193-CD245E0D-B177-43C2-9B0E-BABE34B679B6 Q38103542-36511208-F3F3-4063-A745-A5352D272638 Q38115527-8EF57AB9-D918-415E-A6AC-6DAD8CA716ED Q38206847-B2CD2B3D-E372-49C9-8BE9-03E7A28A3A9F Q38218093-05149821-3D44-4948-8F83-817680B72C26 Q38811310-0C5402C7-AA01-4B90-85E5-3027BF1FBD2D Q39249545-0B5DA329-AAD5-43FF-B656-73CB0BF45CC3 Q39774023-25A7265B-6E4C-4D29-84D5-EEDFB76B1B91 Q41050286-9752F826-4418-4894-8549-EB0B968D0FF9 Q41598733-E5557E5D-C625-4019-9150-A00D05740EA8 Q41682414-964E83B6-76B3-4B02-9379-EEF0224350D7 Q41683734-8698805F-6192-4D1F-A8C8-B3DB3C8E221A Q46353874-A1F30088-2A1A-48C5-8372-3A18AC272B32 Q47397467-EFCF25C2-B311-48EC-965B-4CFE52E34334 Q52722137-F7A15489-217C-4C7D-96BF-666945951F5F Q55362801-73433C33-9452-47F7-A299-5BB86488DAB8

P2860

Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.

http://www.wikidata.org/entity/Q34101137

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@ast

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@en

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@nl

type

label

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@ast

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@en

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@nl

prefLabel

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@ast

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@en

Synergistic inflammation is in ...... s and is blocked by hemopexin.

@nl

P1433

Q34101137-D97E86E3-066E-4B35-8E32-846A7309594B

P1476

Q34101137-F243EE8C-487B-42E9-91D8-99852E3EC518

P2093

Q34101137-098CA5F5-C6B5-4F82-9095-5D7F0E40C424

Q34101137-5832851E-3127-4653-ACAE-7C485DDF08DA

Q34101137-5D158382-DA47-454B-9E3C-98E71DD56239

Q34101137-B8B696E4-BEA3-4098-B0DB-9A0FCC88E9DF

Q34101137-BC726838-2950-406A-9FB7-257A7379F49A

Q34101137-FA7C6265-15A4-4D67-84E2-E923D1B4E2C4

P2860

Q34101137-028E9088-50C4-4066-8937-BC2B6FDA85F5

Q34101137-0F9FDD79-668F-491B-9685-5364308BA072

Q34101137-1413A99B-4E0D-4F03-9E98-ADD8BE63D5C4

Q34101137-1562300A-C89F-414C-B781-83F6BB8605B2

Q34101137-197441C3-59E8-412C-80AA-8A25B4EC6165

Q34101137-1DA42C42-94D6-4B87-83F7-2CC58D17C319

Q34101137-1FB8318C-64E6-4AB8-AE7D-777CD34E800E

Q34101137-23278006-7114-499E-903B-003B14E50973

Q34101137-278861F0-63C5-4BB6-8DD4-3A721A25649D

Q34101137-4C803326-E017-4361-9313-1BE350E51407

P304

Q34101137-A3A03B6E-0198-498A-B37E-3DFBC3D7A2A3

P31

Q34101137-ED7A16F0-DDAC-49F9-991C-47E960FEA432

P356

Q34101137-C52C761D-6F00-495A-AB05-A788168B8CD5

P407

Q34101137-66A631C4-A3EF-4C55-BFAB-DB84F2F4743D

P433

Q34101137-379B982D-F160-46BE-8DF5-3096F307B3AA

P478

Q34101137-E3ABA9CA-B496-4D63-9CB8-A8B24CF2CB46

P50

Q34101137-2AB003B5-2BFD-4476-93B3-4775C8B328FD

Q34101137-5464A125-37DD-468D-A262-C2E80C2DF43A

P577

Q34101137-7EF8C539-1C2A-4DB4-A46C-0ADDA7BDA924

P5875

Q34101137-33347440-7481-4EB5-90E1-BAAF3CD6957F

P698

Q34101137-A0F1958F-7323-4F45-86E6-053DF736DDC0

P921

Q34101137-5570AE34-67C6-49F3-BA3C-D54D60551FD4

P932

Q34101137-4AA179FD-92A5-457D-97E3-834F7671A593

P356

P1433

The Journal of Infectious Diseases

P1476

Synergistic inflammation is in ...... ts and is blocked by hemopexin

@en

P2093

Fatima Sammy

http://www.w3.org/2001/XMLSchema#string

Guangjie Sun

http://www.w3.org/2001/XMLSchema#string

H Shaw Warren

http://www.w3.org/2001/XMLSchema#string

Ping He

http://www.w3.org/2001/XMLSchema#string

Sujatha Thundivalappil

http://www.w3.org/2001/XMLSchema#string

Tian Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein

Resilience to bacterial infection: difference between species could be due to proteins in serum

Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains

Pathogen recognition and innate immunity

Hemopexin: structure, function, and regulation

Toll-like receptors in innate immunity

Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages

Toll-like receptors: critical proteins linking innate and acquired immunity

Nitric oxide and the immune response

P304

624-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/654929

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45147188

http://www.w3.org/2001/XMLSchema#string

P698

20617898

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2932749

http://www.w3.org/2001/XMLSchema#string